Improving Biomarker Driven Precision Therapy in NSCLC: Less Common, More Complex: Multidisciplinary Discussion of Safety and Efficacy of TKIs for Rare Mutations in NSCLC September 29, 2021

Improving Biomarker Driven Precision Therapy in NSCLC: The Importance of an Integrated Multidisciplinary Approach Part 2 - Less Common, More Complex: Multidisciplinary Discussion of Safety and Efficacy of TKIs for Rare Mutations in NSCLC
Category
- Hematology/Oncology
Format
- Online live
Credits
- ACPE Pharmacy
- AMA PRA Category 1 Credit™
- ANCC
- Participation